Logo of TCD Capital, which leads to the homepage when clicked.

Graftys is active in medtech’s market, is one of the world leaders in synthetic resorbable orthopaedic cements, with a pipeline of 2 marketed products (registered in 27 countries).

Following to the capital increase structured by TCD Capital, Graftys has relocated its headquarters in Wallonia from France while refocusing its French unit (located in Aix-en-Provence) around its core cement production skills.

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

TCD Form Template Style